Revvity financials
$152.77+1.16%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 28 | FY24 Dec 29 | FY23 Dec 31 |
|---|---|---|---|
| Revenue | $2.86B | $2.76B | $2.75B |
| Gross profit | $1.56B | $1.54B | $1.54B |
| Gross margin | 54.8% | 55.8% | 56.0% |
| Operating income | $356.6M | $346.7M | $300.6M |
| Net income | $241.2M | $270.4M | $693.1M |
| Net margin | 8.4% | 9.8% | 25.2% |
| Diluted EPS | $2.07 | $2.20 | $5.55 |
| EBITDA | $762.0M | $774.6M | $732.3M |
| Operating cash flow | $582.9M | $628.3M | $91.3M |
| Free cash flow | $509.4M | $541.7M | $9.9M |
| Diluted shares | 116.6M | 122.8M | 124.8M |
Balance sheet
| Period end | Dec 28 | Dec 29 | Dec 31 |
|---|---|---|---|
| Cash & equivalents | $919.9M | $1.16B | $913.2M |
| Short-term investments | $0.00 | $0.00 | $689.9M |
| Total debt | $3.22B | $3.15B | $3.90B |
| Total assets | $12.17B | $12.39B | $13.56B |
| Total liabilities | $4.92B | $4.73B | $5.69B |
| Shareholders' equity | $7.25B | $7.67B | $7.87B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology